Sign in

CIK 0000879407

  • Large accelerated filer

ARROWHEAD PHARMACEUTICALS, INC.

Sign in to watch
Ticker
ARWR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
DE
Entity type
Operating
EIN
460408024
Phone
+1 626-696-4702
Business address
177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
Former names
ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 48 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2014-01-02 Lewis David L. Chief Scientific Officer Option exercise +2,500 $2.62 $7K 15,000
2014-01-02 Lewis David L. Chief Scientific Officer Sale −15,000 $10.29 $154K 0
2014-01-02 Lewis David L. Chief Scientific Officer Option exercise · Stock Option −10,000 202,500
2014-01-02 Lewis David L. Chief Scientific Officer Option exercise · Stock Option −2,500 200,000
2014-01-02 Lewis David L. Chief Scientific Officer Option exercise · Stock Option −2,500 197,500
2013-10-28 Ferrari Mauro Director Purchase +400 $7.62 $3K 4,251
2013-10-11 McKenney Charles Director Grant or award +1,200 $7.58 $9K 2,220
2013-10-09 Ferrari Mauro Director Purchase +1,900 $6.19 $12K 3,851
2013-09-21 FRYKMAN EDWARD W Director Grant or award · Stock Option +7,000 82,500
2013-09-21 PERRY MICHAEL S Director Grant or award · Stock Option +7,000 77,000
2013-09-21 GIVEN DOUGLAS B Director Grant or award · Stock Option +7,000 72,000
2013-09-21 McKenney Charles Director Grant or award · Stock Option +7,000 75,000
2013-09-21 Myszkowski Kenneth Allen CFO Grant or award · Stock Option +20,000 278,000
2013-09-21 GIVEN BRUCE D Chief Operating Officer Grant or award · Stock Option +40,000 386,000
2013-09-21 Anzalone Christopher Richard President and CEO Grant or award · Stock Option +69,991 726,466
2013-05-06 Anzalone Christopher Richard President and CEO Grant or award · Stock Option +200,000 656,475
2013-05-06 GIVEN BRUCE D Chief Operating Officer Grant or award · Stock Option +170,000 346,000
2013-05-06 Myszkowski Kenneth Allen CFO Grant or award · Stock Option +90,000 258,000
2013-05-06 GIVEN DOUGLAS B Director Grant or award · Stock Option +5,000 65,000
2013-05-06 PERRY MICHAEL S Director Grant or award · Stock Option +5,000 70,000

Page 41 of 46 · 902 trades